Today Oppenheimer reiterates an Outperform rating on Gilead Sciences (NASDAQ: GILD) with a price target of $80.00.

Analyst David ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE